| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 504414-06-6 | 4-Fluoro-2-hydroxy-5-methylbenzaldehyde | C8H7FO2 |
| 504433-23-2 | 1,3-Dihydro-3-[(1-methyl-1H-indol-3-yl)methylene]-2H-pyrrolo[3,2-b]pyridin-2-one | C17H13N3O |
| 504438-22-6 | (5R)-3-[3-Fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-5-(hydroxymethyl)-2-oxazolidinone | C16H21BFNO5 |
| 504440-63-5 | 7-Hydroxy-1H-pyrrolo[2,3-b]pyridinium | C7H7N2O |
| 505082-81-5 | 3',4'-Difluorobiphenyl-4-carboxylic acid | C13H8F2O2 |
| 505083-04-5 | 3-Fluoro-4-(methoxycarbonyl)benzeneboronic acid | C8H8BFO4 |
| 505084-55-9 | 2-Chloro-4-iodo-5-(trifluoromethyl)pyridine | C6H2ClF3IN |
| 505084-56-0 | 2-Chloro-3-iodo-5-(trifluoromethyl)pyridine | C6H2ClF3IN |
| 505084-57-1 | 2-Chloro-5-(trifluoromethyl)-4-pyridinecarboxaldehyde | C7H3ClF3NO |
| 505084-58-2 | 2-Chloro-5-(trifluoromethyl)pyridine-4-carboxylic acid | C7H3ClF3NO2 |
| 505084-59-3 | 2-Chloro-5-(trifluoromethyl)pyridine-3-carboxylic acid | C7H3ClF3NO2 |
| 506407-82-5 | 2,4,6-Trifluoro-5-iodo-1,3-phenylene | C6F3I |
| 506410-53-3 | Graveobioside A | C26H28O15 |
| 506417-41-0 | Dichlorobis(2-(diphenylphosphino)ethylamine)ruthenium(II) | C28H32Cl2N2P2Ru |
| 506421-86-9 | L-Leucyl-L-leucyl-L-leucyl-L-leucyl-L-alpha-aspartyl-L-valyl-L-alanyl-L-prolyl-L-leucine | C47H83N9O12 |
| 506421-88-1 | L-Leucyl-L-leucyl-L-alpha-aspartyl-L-valyl-L-alanyl-L-prolyl-L-leucyl-L-seryl-L-leucine | C44H77N9O13 |
| 506426-96-6 | 5-[[4-(Diphenylamino)phenyl]methylene]-3-(2-phenylethyl)-2,4-oxazolidinedione | C30H24N2O3 |
| 506429-76-1 | L-Seryl-L-glutaminyl-L-lysyl-L-threonyl-L-tyrosyl-L-glutaminylglycyl-L-seryl-L-tyrosine | C46H68N12O17 |
| 507276-74-6 | N-[(1,1-Dimethylethoxy)carbonyl]-O-(1,1-dimethylethyl)-D-tyrosine | C18H27NO5 |
| 507462-51-3 | 5-Bromo-1H-pyrrolo[2,3-b]pyridin-3-amine | C7H6BrN3 |
| 507472-13-1 | (betaS)-beta-[[(9H-Fluoren-9-ylmethoxy)carbonyl]amino]-2-fluorobenzenepropanoic acid | C24H20FNO4 |
| 507472-14-2 | (betaS)-beta-[[(9H-Fluoren-9-ylmethoxy)carbonyl]amino]-3-fluorobenzenepropanoic acid | C24H20FNO4 |
| 507472-15-3 | (betaS)-2-Chloro-beta-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]benzenepropanoic acid | C24H20ClNO4 |
| 507472-16-4 | (betaS)-3Chloro-beta-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]benzenepropanoic acid | C24H20ClNO4 |
| 507472-17-5 | (betaS)-2-Bromo-beta-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]benzenepropanoic acid | C24H20BrNO4 |
| 507472-18-6 | (betaS)-3-Bromo-beta-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]benzenepropanoic acid | C24H20BrNO4 |
| 507472-20-0 | (betaS)-beta-[[(9H-Fluoren-9-ylmethoxy)carbonyl]amino]-3-(trifluoromethyl)benzenepropanoic acid | C25H20F3NO4 |
| 507472-25-5 | (betaS)-beta-[[(9H-Fluoren-9-ylmethoxy)carbonyl]amino]-2-nitrobenzenepropanoic acid | C24H20N2O6 |
| 507475-17-4 | TPCA-1 | C12H10FN3O2S |
| 508172-17-6 | (SP-5-53)-[1,3-Bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene]carbonylchlorohydro(tricyclohexylphosphine)ruthenium | C40H60ClN2OPRu |
| 508177-67-1 | 4-Fluoro-3-methoxybenzenemethanamine | C8H10FNO |
| 508182-41-0 | Ganoderic acid LM2 | C30H42O7 |
| 508186-08-1 | N1-(2,3-Di-2-furanyl-6-quinoxalinyl)-N3,N3-diethyl-1,3-piperidinedicarboxamide | C27H29N5O4 |
| 508186-14-9 | N-(2,3-Di-2-thienyl-6-quinoxalinyl)-N'-(2-methoxyethyl)urea | C20H18N4O2S2 |
| 508201-22-7 | N-4-Piperidinyl-4-piperidinamine | C10H21N3 |
| 508230-31-7 | L-Leucyl-L-leucyl-L-alpha-glutamyl-L-phenylalanyl-L-tyrosyl-L-leucyl-L-alanyl-L-methionyl-L-prolyl-L-phenylalanyl-L-alanyl-L-threonyl-L-prolyl-L-methionyl-L-alpha-glutamyl-L-alanyl-L-alpha-glutamyl-L-leucyl-L-alanyl-L-arginyl-L-arginyl-L-seryl-L-leucyl-L-alanyl-L-glutamine | C131H206N32O36S2 |
| 508230-35-1 | L-Methionyl-L-prolyl-L-arginyl-L-alpha-glutamyl-L-alpha-aspartyl-L-alanyl-L-histidyl-L-phenylalanyl-L-isoleucyl-L-tyrosylglycyl-L-tyrosyl-L-prolyl-L-lysyl-L-lysylglycyl-L-histidylglycyl-L-histidyl-L-serine | C105H151N31O28S |
| 508233-74-7 | Vortioxetine | C18H22N2S |
| 508233-76-9 | 1-[2-[(2,6-Dimethylphenyl)thio]phenyl]piperazine | C18H22N2S |
| 508233-98-5 | alpha-(Aminomethyl)-1H-indole-5-methanol | C10H12N2O |
| 508234-03-5 | Vortioxetine Impurity 3 | C17H20N2S .HCl |
| 508235-16-3 | (2,3-Difluoro-4-methylphenyl)boronic acid | C7H7BF2O2 |
| 508241-14-3 | (9aR)-Octahydropyrazino[2,1-c][1,4]oxazine | C7H14N2O |
| 509072-57-5 | 2,2-Difluorocyclopropylmethanol | C4H6F2O |
| 509074-26-4 | 4-(5-Methyl-3-phenyl-4-isoxazolyl)benzenesulfonyl chloride | C16H12ClNO3S |
| 509077-91-2 | Taiwanhomoflavone B | C32H24O10 |
| 509078-16-4 | 1beta-Hydroxytorilin | C22H32O6 |
| 509078-28-8 | Dihydro-5-[(3,4,5-trihydroxyphenyl)methyl]-2(3H)-furanone | C11H12O5 |
| 509088-69-1 | KRP-203 | C24H26ClNO3S.HCl |
| 509093-47-4 | IRAK-1-4 Inhibitor I | C20H21N5O4 |